We are live on ! Find out more
MIRA icon

MIRA Pharmaceuticals
MIRA

11 hedge funds and large institutions have $454K invested in MIRA Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.48% more ownership

Funds ownership: 4.34% → 4.82% (+0.48%)

0% more funds holding

Funds holding: 11 → 11 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

36% less capital invested

Capital invested by funds: $704K → $454K (-$250K)

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
APP
Avantax Planning Partners
Iowa
+$97.6K
2
UBS Group
UBS Group
Switzerland
+$20.4K
3
Citadel Advisors
Citadel Advisors
Florida
+$20K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$16.4K
5
TSS
Two Sigma Securities
New York
+$14.7K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$69K
2
HF
HRT Financial
New York
-$33K
3
XT
XTX Topco
Cayman Islands
-$28.1K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$17.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CSI
1
Cross Staff Investments
New York
$244K – – –
APP
2
Avantax Planning Partners
Iowa
$75.6K +$97.6K +118,751 New
SEM
3
Suncoast Equity Management
Florida
$25.5K – – –
UBS Group
4
UBS Group
Switzerland
$18.8K +$20.4K +24,775 +519%
PWM
5
Praetorian Wealth Management
California
$17.5K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$16.1K +$20K +24,396 New
Northern Trust
7
Northern Trust
Illinois
$13K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$12.7K +$16.4K +20,001 New
FAB
9
First American Bank
Illinois
$12.7K – – –
TSS
10
Two Sigma Securities
New York
$11.4K +$14.7K +17,869 New
CSPIA
11
Cary Street Partners Investment Advisory
Virginia
$6.37K – – –
VF
12
Virtu Financial
New York
– -$69K -63,055 Closed
HF
13
HRT Financial
New York
– -$33K -30,651 Closed
XT
14
XTX Topco
Cayman Islands
– -$28.1K -25,544 Closed
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
– -$17.1K -15,573 Closed

MIRA Hedge Fund Activity: Q2 2024 in Review

11 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in MIRA Pharmaceuticals (MIRA) for Q2 2024, worth a combined $454K — down 36% from $704K a quarter earlier.

Fund positioning in MIRA was balanced in Q2 2024: 4 funds opened new positions, 4 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Avantax Planning Partners, opening a new position worth an estimated $97.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $69K sold.

  • 11 institutional investors held MIRA Pharmaceuticals (MIRA) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $454K of MIRA Pharmaceuticals stock for Q2 2024, down 36% quarter-over-quarter.
  • 4 funds opened new MIRA Pharmaceuticals positions in Q2 2024 and 4 closed out, a net change of 0 holders.
  • The largest MIRA Pharmaceuticals buyer in Q2 2024 was Avantax Planning Partners, an estimated $97.6K added.
  • The largest MIRA Pharmaceuticals seller in Q2 2024 was Virtu Financial, an estimated $69K sold.

Based on aggregated 13F filings for Q2 2024.